Comparison of the effect Of Metformin and Pioglitazone on hypertriglyceridemia(Dyslipidemia)

Phase 1

Recruiting

• Conditions: Condition 1: Hypertriglyceridemia. Condition 2: Metabolic syndrom.; Pure hyperglyceridemia; Metabolic syndrome; E78.1; E88.81

• Registration Number: IRCT20230618058524N1
• Lead Sponsor: Islamic Azad University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 July 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 68

Inclusion Criteria

Age : 25 - 70 ( male, female )
Triglyceride over than 150 mg/dl
25 < BMI < 40
Not using of Metformin, Pioglitazone
Not using of Statin drugs

Exclusion Criteria

Underlying diseases such as Diabetes, Hypothyroidism, Heart diseases, Kidney failure, Liver failure, Severe infections, Cancer, Inflammatory diseases such as Rheumatoid arthritis and Inflammatory bowel disease.
Drug side effects caused by Metformin and Pioglitazone
Patients with familial hypertriglyceridemia
Patients with Osteoporosis
Pregnancy
Breastfeeding
Having diabetes
Alcohol consumption, Addictive drugs
BMI > 40 kg/m2
Dissatisfaction with participating or continuing to attend the study
Patients with special diets
Users of Statins and other Fat-lowering drugs, Corticosteroids

Study & Design

• Study Type: interventional
• Study Design: Not specified